Oxford Medical Products Limited

Oxford Medical Products Limited (OMP) is a United Kingdom-based medical technology company headquartered in Witney. The company has developed a proprietary gastroretentive hydrogel platform, which it describes as the first hydrogel technology of its kind with multiday gastroretention. The platform is designed so that a patient swallows a hydrogel pill; once in the stomach, the pill swells rapidly — in under 30 minutes — to the size of a large marshmallow. The swollen pill remains in the stomach for a pre-determined number of days, with formulations tuneable to offer a range of one to seven days of gastroretention, before the gel breaks down and is excreted naturally. OMP applies this single platform across two therapeutic pathways. The first is weight management, commercialised under the product name Sirona, a non-pharmacological treatment designed to help people manage overweight and obesity. The second is drug delivery, through OMP GEL GRDDS (gastroretentive drug delivery system), which facilitates controlled, long-term gastroretentive delivery of small molecules and biologics. The company also indicates further applications in nutraceutical delivery and biosensors. According to the company's published FAQs, Sirona is taken as one to three pills once a day, first thing in the morning, depending on individual needs. The pill cannot expand in the throat because it requires a substantial volume of water to swell fully, which is available only once the capsule reaches the stomach. Company data indicates the swollen pill stays in the stomach for two to five days, providing prolonged appetite suppression, before natural stomach contractions break it into smaller pieces that pass through the gastrointestinal tract and are excreted like food. OMP states that the pill does not dissolve and none of its contents enter the bloodstream, which it cites as the basis for a favourable safety profile. Across clinical studies to date, the company reports having dosed over 9,500 Sirona pills, which it says have consistently passed through the gastrointestinal tract without causing blockages. OMP is a private company and presents itself as platform-driven, with a pipeline spanning obesity treatment, drug delivery, nutraceuticals and biosensors. Its investor base is referenced on its website, though specific ownership and funding details are not disclosed in the available evidence.

Oxford Medical Products Limited is a United Kingdom company headquartered in Witney. Public evidence about its corporate history is limited; the available sources describe the company primarily through its technology platform and product pipeline rather than through a dated corporate timeline. The company's central asset is a proprietary gastroretentive hydrogel platform, which it describes as the first hydrogel technology of its kind with multiday gastroretention. The platform works by having a patient swallow a hydrogel pill that swells rapidly in the stomach — in under 30 minutes — to the size of a large marshmallow. The swollen pill remains in the stomach for a pre-determined number of days, and the system is tuneable, with OMP able to create formulations offering a range of one to seven days of gastroretention. After that period, the swollen gel breaks down and is excreted naturally. From this single platform, OMP has developed two therapeutic applications. The first is weight management, marketed under the name Sirona, a non-pharmacological treatment designed to help people manage overweight and obesity. The second is drug delivery, through OMP GEL GRDDS (gastroretentive drug delivery system), which facilitates controlled, long-term gastroretentive delivery of small molecules and biologics. The company also points to further applications in nutraceutical delivery and biosensors. OMP has published detailed information about how Sirona is used and how it behaves in the body. Patients take one to three pills once a day, first thing in the morning, with the number depending on individual needs. The pill cannot expand in the throat because it requires a substantial volume of water to swell fully, which is available only once the capsule reaches the stomach. Company data shows the pill stays in the stomach for two to five days, providing prolonged appetite suppression, before it breaks into smaller pieces and is excreted naturally, like food. OMP states that participants in its studies did not report being able to feel the swollen pills in the stomach, and that the stomach's natural contractions break the pill into smaller pieces of soft hydrogel that pass through the gastrointestinal tract. The company emphasises that the pill does not dissolve and that none of its contents enter the bloodstream, which it cites as the reason for its favourable safety profile. On the question of obstruction, OMP states that across its clinical studies to date it has dosed over 9,500 Sirona pills, which have consistently passed through the gastrointestinal tract without causing blockages. OMP is a private company. Its website references its investors, but the available evidence does not disclose specific ownership, funding rounds, or a dated corporate history. The company's public identity is therefore that of a platform technology developer advancing a gastroretentive hydrogel across obesity treatment, drug delivery, and adjacent applications.

Developer of a proprietary gastroretentive hydrogel platform spanning non-pharmacological obesity treatment and controlled drug delivery.

• Sirona

  A non-pharmacological weight management treatment designed to help people manage overweight and obesity. Taken as one to three pills once a day, first thing in the morning. The pill swells in the stomach to the size of a large marshmallow and stays there for two to five days, providing prolonged appetite suppression before breaking down and being excreted naturally.

• OMP GEL GRDDS

  A gastroretentive drug delivery system that facilitates controlled, long-term gastroretentive delivery of small molecules and biologics.

1. 1Oxford Medical Productsoxfordmedicalproducts.com
2. 2FAQs about Sirona — Oxford Medical Productsoxfordmedicalproducts.com
3. 3Oxford Medical Products Limited (United Kingdom) — Wikidatawikidata.org